Welcome to our dedicated page for AETERNUM HEALTH SEC filings (Ticker: AETN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on AETERNUM HEALTH's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into AETERNUM HEALTH's regulatory disclosures and financial reporting.
Aeternum Health, Inc. (formerly Shorepower Technologies) has completed its merger with Aeternum Health LLC, triggering a change of control and a complete shift in strategy. Former CEO Jeff Kim resigned and Paul Mann, Aeternum’s manager, became CEO and sole director.
Under the merger, Mann received 49,000,000 shares of common stock, giving him 51% ownership, plus 2,000,000 shares of Series B preferred stock, each carrying the voting power of 40 common shares. The company is pivoting away from transportation electrification to focus on critical minerals mining and potential longevity-related products, supported by at least $1,500,000 of assets, including a minimum of $300,000 in cash to be contributed.
Following the deal, the company changed its name to Aeternum Health, increased authorized shares from 100 million to 250 million and now has 96,105,204 common shares and 2,000,000 Series B preferred shares outstanding. Management discloses substantial doubt about its ability to continue as a going concern due to large accumulated deficits, continuing losses, no cash at year-end 2025, penny stock status and the need for significant additional capital to execute its new, early-stage business plan.
Aeternum Health, Inc. (formerly Shorepower Technologies) reports a sharp downturn in operations and prepares a major business pivot. Q1 2026 revenue fell to $2,260 from $164,657 a year earlier, producing a negative gross margin of $11,977 and a net loss of $139,655 after prior-year net income.
At March 31, 2026, the company held cash of $19,156, had a working capital deficit of $1,158,363, total liabilities of $2,137,041, and an accumulated deficit of $3,417,796, leading management to disclose substantial doubt about its ability to continue as a going concern. Operations are being funded through related-party loans and small equity raises.
The company has signed a merger agreement with Aeternum Health LLC under which it will divest its transportation electrification business and refocus on longevity and anti‑aging healthcare. Aeternum will contribute at least $1.5 million in cash plus intellectual property, while Paul Mann will receive 51% of the common equity and 2,000,000 Series B preferred shares with super‑voting rights. Existing CEO Jeff Kim has agreed to cancel up to 13,000,000 common shares, and authorized common stock has been increased from 100,000,000 to 250,000,000 to support the transaction.
ShorePower Technologies Inc. notified the SEC it cannot timely file its Form 10-Q for the quarter ended March 31, 2026.
The company states it needs additional time to compile and analyze supporting documentation and to allow its independent registered public accounting firm to complete its review; it intends to file the Form 10-Q as soon as possible.